Drug Delivery Systems Market revenue to exceed USD 433 Billion by 2035, says Research Nester
18 mars 2024 05h00 HE
|
Research Nester
New York, March 18, 2024 (GLOBE NEWSWIRE) -- The global drug delivery systems market size is slated to expand at ~11% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 433...
Transdermal Patches Market is Expected to Reach $8.0 Billion | MarketsandMarkets.
08 déc. 2023 07h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Transdermal Patches market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $8.0 billion by 2029, growing at a...
Analgesics Market to Reach USD 56.86 Million by 2030, States a New Report by Next Move Strategy Consulting
09 févr. 2023 09h00 HE
|
Next Move Strategy Consulting
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Global Analgesics Market is estimated to be USD 35.03 million in 2021 and is...
Global Advanced Drug Delivery Market Anticipated to Generate a Revenue of $94,352.5 Million and Rise at a CAGR of 10.0% during the Analysis Timeframe from 2021 to 2028 [175-Pages] | Announced by Research Dive
06 févr. 2023 09h00 HE
|
Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global advanced drug delivery market is projected to generate a revenue of $94,352.5 million...
US Transdermal Patch Drug Delivery Market Size Clinical Trials Forecast 2026
18 nov. 2021 08h14 HE
|
KuicK Research
Delhi, Nov. 18, 2021 (GLOBE NEWSWIRE) -- US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026 Report Highlights: US Transdermal Patch Market InsightUS Transdermal Patch...
IntelGenx to Join the Quebec Pavilion at BIO 2019 International Convention
23 mai 2019 08h00 HE
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it will be joining the Quebec...
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome
09 juil. 2018 06h55 HE
|
Zynerba Pharmaceuticals, Inc.
Study will Evaluate the Efficacy and Safety of Transdermally-Delivered Cannabidiol (CBD) in Children and Adolescents with Fragile X Syndrome Top Line Results Expected in Second Half of 2019 Zynerba...
NanoSphere Health Sciences: Advancing the Industry with Breakthrough Cannabinoid Delivery -- CFN Media
10 mai 2018 08h45 HE
|
CFN Media
SEATTLE, May 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an...
NanoSphere Health Sciences Achieves Landmark Patent -- CFN Media
10 avr. 2018 08h30 HE
|
CFN Media; NanoSphere Health Sciences Inc.
SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of...
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
14 mars 2018 07h45 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women's healthcare company today announced that an abstract related to the Phase 3 SECURE study for...